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Abstract
Numerous in vitro studies have shown that toll-like receptor signaling induces 25-hydroxyvitamin D3 1a-hydroxylase (1a-
OHase; CYP27B1) expression in macrophages from various species. 1a-OHase is the primary enzyme that converts 25-
hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). Subsequently, synthesis of 1,25(OH)2D3 by 1a-OHase in
macrophages has been shown to modulate innate immune responses of macrophages. Despite the numerous in vitro
studies that have shown 1a-OHase expression is induced in macrophages, however, evidence that 1a-OHase expression is
induced by pathogens in vivo is limited. The objective of this study was to evaluate 1a-OHase gene expression in
macrophages and mammary tissue during an in vivo bacterial infection with Streptococcus uberis. In tissue and secreted cells
from the infected mammary glands, 1a-OHase gene expression was significantly increased compared to expression in tissue
and cells from the healthy mammary tissue. Separation of the cells by FACS9 revealed that 1a-OHase was predominantly
expressed in the CD14
+ cells isolated from the infected mammary tissue. The 24-hydroxylase gene, a gene that is highly
upregulated by 1,25(OH)2D3, was significantly more expressed in tissue and cells from the infected mammary tissue than
from the healthy uninfected mammary tissue thus indicating significant local 1,25(OH)2D3 production at the infection site. In
conclusion, this study provides the first in vivo evidence that 1a-OHase expression is upregulated in macrophages in
response to bacterial infection and that 1a-OHase at the site of infection provides 1,25(OH)2D3 for local regulation of vitamin
D responsive genes.
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Introduction
Vitamin D has been shown to have a role in regulating immune
function in addition to the well-known role it has in regulating
calcium homeostasis. 1,25-dihydroxyvitamin D3 (1,25(OH)2D3),
the active vitamin D3 metabolite, regulates the expression of
several genes involved in host defense and immune function [1].
Therefore, synthesis of 1,25(OH)2D3 to control vitamin D
responsive genes in immune cells is a critical factor in regulating
of immune function.
The enzyme that synthesizes 1,25(OH)2D3 from 25-hydroxyvi-
tamin D3 (25(OH)D3)i s1 a-hydroxylase (1a-OHase; CYP27B1)
[2]. In the kidney, 1a-OHase expression is induced by parathyroid
hormone in response to calcium homeostasis [3,4]. Synthesis of
1,25(OH)2D3 in the kidney regulates the circulating concentration
of 1,25(OH)2D3 and the endocrine actions of vitamin D. In
monocytes and macrophages, 1a-OHase is expressed in response
to activation by IFN-c or TLR signaling [5,6,7,8]. Conversion of
25(OH)D3 to 1,25(OH)2D3 by 1a-OHase in monocytes regulates
the expression of vitamin D responsive genes in an intracrine
manner [9]. In human monocytes, production of 1,25(OH)2D3 by
1a-OHase drives cathelicidin gene expression [6]. In the same
way, 1a-OHase activity in bovine monocytes enhances iNOS and
RANTES gene expression [8]. From in vitro studies, expression of
1a-OHase by macrophages at the site of an infection seems to be
an important part of innate immunity. Montoya et al have shown
that upregulation of the vitamin D pathway occurs in leprosy
lesions of patients with self limiting forms of the disease [10],
however, beyond that study there is no evidence that 1a-OHase is
expressed by macrophages in vivo as a result of experimental
infection [11].
Intra-mammary infections during lactation offers a model of
bacterial infection to determine if 1a-OHase is expressed in
response to bacterial infection in vivo. Common pathogens that
cause mammary infections include Escherichia coli, Staphylococcus
aureus, and Streptococcus uberis [12,13,14,15]. During mammary
infection the number of somatic cells secreted in milk will often
exceed 10
6 cells/mL. Approximately 80 to 90 percent of somatic
cells in milk from an infected mammary gland are neutrophils and
the remainder of the cells are macrophages and lymphocytes [16].
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15469The advantage of using a mammary infection model is that the
infiltrating cells during mammary infection can easily isolated from
milk using non-invasive procedures; allowing us to study the in
vivo immune responses of immune cells to bacterial infection.
TLRs are present in the bovine mammary gland [17] and
invasion of the mammary gland by bacteria triggers an innate
immune response by TLR signaling [18]. Based on in vitro
evidence that 1a-OHase expression in macrophages is induced by
TLR recognition of bacteria [6,8,19], we hypothesized that 1a-
OHase expression would be upregulated in both macrophages and
mammary tissue during a mammary infection. Using an intra-
mammary infection as a model in vivo bacterial infection, we
present the first in vivo evidence that 1a-OHase expression is
upregulated in CD14
+ cells that are at the site of a bacterial
infection. The subsequent large increased expression of 24-
hydroxylase (24-OHase) at the infection site supports local in vivo
production of 1,25(OH)2D3 at the site of an infection.
Materials and Methods
Animals
Eight, mid-lactation Holstein cows at the USDA National
Animal Disease Center were used for this study. The National
Animal Disease Center animal care and use committee approved
all procedures used in this study (Protocol ARS-4001). Prior to the
study, all cows were healthy and bacteria were not detected in
their milk. Mammary infection was induced by infusion of 500 cfu
of Streptococcus uberis strain 0140 (S. uberis; a gift from Dr. Max
Paape, USDA, Beltsville, MD) suspended in 3 mL of PBS into one
mammary gland. The contra lateral gland was infused with an
equal volume of PBS and served as the control. The amount of S.
uberis in the milk from the control and infected glands was
determined by culturing log dilutions of milk samples on blood
agar plates for 24 hours at 37uC.
Collection of tissue and cells
Mammary tissue was collected from various locations in the
control and infected glands of three cows that were euthanized at
the onset of clinical mammary infection. Clinical infection was
defined by rectal temperature, noticeable inflammation, and
presence of bacteria in the milk. Tissue was placed in RNAlater
(Qiagen, Valencia, CA), snap frozen in liquid nitrogen and stored
at 280uC.
Cells were isolated from milk from the control and infected
glands and peripheral blood of 5 cows before infection with S.
uberis and at the onset of clinical mastitis. Cells were isolated from
milk by centrifuging the milk at 1000Xg for 20 min. Peripheral
blood leukocytes were isolated by lysing the erythrocytes with a
hypotonic buffer and centrifuging at 6506g for 10 min. The cell
pellets from milk and blood were washed 3X by resuspending in
cold PBS and centrifuging at 6506g for 10 min. Cells were lysed
with RLT buffer (Qiagen) and stored at 280uC or separated by
FACS.
For separation of cells from blood and milk by FACS, cells were
labeled with monoclonal anti-bovine CD14 IgG1 (CAM36A;
VMRD, Inc., Pullman, WA) and a PE-conjugated anti-mouse IgG
antibody (Southern Biotech, Birmingham, AL). Labeled cells were
separated based on fluorescence intensity using the BD FACSAria
Cell Sorting System (BD Biosciences, San Jose, CA). Approxi-
mately 10
6 CD14
+ and CD14
2 cells with greater than 95% purity
were isolated from milk from the infected gland and peripheral
blood of each animal. The sorted cells were lysed with RLT buffer
(Qiagen) and stored at 280uC.
Real-time PCR
RNA was isolated from mammary tissue and cells using an
RNeasy Mini Kit (Qiagen). RNA samples were eluted in 50 mLo f
RNAse-free water. Immediately after elution, RNA was reverse
transcribed to cDNA using a High Capacity Reverse Transcription
Kit (Applied Biosystems, Foster City, CA) with 10 mL RNA sample
and 20 units of RNase inhibitor (RNaseOUT, Invitrogen, Carlsbad,
CA) in a 20 mL reaction. Reactions were incubated at 37uC for 2 h
and heated to 85uC for 5 s. The cDNA samples were diluted 1:10 in
water and stored at 220uC. Real-time PCR was performed using a
7300 Real-Time PCR System (Applied Biosystems). The reactions
wereincubatedat95uCfor10 minfollowedby40cyclesof95uCfor
15 s and 60uC for 1 min. Each reaction contained 12.5 mL SYBR
Green PCR Master Mix (Applied Biosystems), 2.5 mL each of
10 mM forward and reverse primers, and 7.5 mL of diluted cDNA.
Sequences for primer pairs are given in Table 1. Primers were
purchased from Integrated DNA Technologies (Corralville, IA).
The specificity of each primer pair was determined by gel
electrophoresis of cDNA products and efficiency was determined
using known dilutions of cDNA. All primer pairs, except for the
VDR, have been used previously [8]. Relative gene expression was
determined using the 2
-DDCt method [20]. RPS9 was used as the
Table 1.
Gene (alternate name) Accesion no.
1 Strand Sequence (59 -3 9)
1a-OHase (CYP27B1)
2 NM_001192284 Forward
Reverse
TGGGACCAGATGTTTGCATTCGC
TTCTCAGACTGGTTCCTCATGGCT
24-OHase (CYP24A1)
2 NM_001191417 Forward
Reverse
GAAGACTGGCAGAGGGTCAG
CAGCCAAGACCTCGTTGATT
iNOS
2 NM_001076799 Forward
Reverse
GATCCAGTGGTCGAACCTGC
CAGTGATGGCCGACCTGATG
RANTES (CCL5)
2 NM_175827 Forward
Reverse
CACCCACGTCCAGGAGTATT
CTCGCACCCACTTCTTCTCT
RPS9
2 NM_001101152 Forward
Reverse
GTGAGGTCTGGAGGGTCAAA
GGGCATTACCTTCGAACAGA
VDR NM_001167932 Forward
Reverse
AGCCACCGGCTTCCATTTCA
AACAGCGCCTTCCGCTTCAT
1Accesion numbers from NCBI database http://www.ncbi.nlm.nih.gov.
2Primer sequences have been published previously [8].
doi:10.1371/journal.pone.0015469.t001
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gene expression and the relative expression of RPS9 did not differ
significantly among treatments.
Statistical analysis
Statistical analysis was performed using PROC GLM of SAS
(SAS Institute Inc., Cary, NC). The model used in the analysis
accounted for effects of treatment and cow. DDCt values were used
to analyze relative gene expression. Mean DDCt values 6 SE were
transformed (2
-DDCt) and shown as the expression relative to the
control. The control treatment is designated in the figure legends.
Multiple comparison tests of the means were made with the
Tukey-Kramer adjustment.
Results
Streptococcus uberis mammary infection
Eight cows were infused with 500 CFUs of S. uberis strain 0140
in one mammary gland and sterile PBS in the contra-lateral
mammary gland. Bacteria were not detected in milk from any of
the mammary glands prior to infection and were not detected in
the milk from the control mammary glands during infection
(Fig. 1A). The average amount of S. uberis in the milk from the
infected mammary glands at the peak of the disease was
10
8 CFU/mL (Fig. 1A). Prior to infection cows had normal body
temperatures, but during mammary infection body temperatures
were elevated (Fig. 1B). The number of somatic cells in the milk
from the infected mammary glands rose from an average of 10
5
cells/mL prior to infection to over 10
7 cells/mL during the
infection (Fig. 1C). The number of somatic cells in the control
mammary glands remained near 10
5 cells/mL on average during
infection (Fig. 1C). Examination of mammary tissue by micros-
copy revealed inflammation and the presence of infiltrating cells in
the alveoli of the infected mammary gland (Fig. 1D). The onset of
clinical infection was typically 3 days after infection with S. uberis;
which was consistent with previous studies with S. uberis [21]. The
mean concentration of 25(OH)D in blood of the cows used in this
study was 74.5 ng/ml (SEM +/24.5) and the concentration of
25(OH)D in blood was not affected by onset of mastitis.
1a-Hydroxylase gene expression during mastitis
Inourinitialexperiment,secretorymammary tissue wascollected
from the control and infected glandsof 3 cows at theonset ofclinical
mammary infection. In the tissue from the infected mammary
glands, 1a-OHase expression was nearly 50 fold greater than 1a-
OHase expression in tissue from the contra-lateral uninfected
mammary glands (P,0.001; Fig. 2A). The alveoli in the infected
mammary tissue were packed with infiltrating cells (Fig. 1D) and the
Figure 1. Intra-mammary infection with Streptococcus uberis. Five hundred CFU of S. uberis strain 0140 were infused into the mammary glands
of 8 healthy cows. The contra-lateral glands were infused with 3 mL of PBS and served as the controls. Prior to infection, all glands were free of
bacteria. The average CFU of S. uberis in milk (A), rectal temperatures (B), and number of somatic cells in milk (C) prior to and during infection are
shown. Error bars represent the SE. (D) Representative tissue sections at 20X magnification from the control and infected mammary gland.
doi:10.1371/journal.pone.0015469.g001
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mastitis [16], were hypothesized to be the cells expressing 1a-
OHase. Therefore, to determine the contribution of infiltrating cells
on 1a-OHase gene expression during mastitis we isolated cells from
the milk of control and infected mammary glands from 5 cows with
S. uberis. In cells isolated from milk from the infected mammary
glands, 1a-OHase gene expression was 40 fold greater than
expression in cells from the contra-lateral uninfected mammary
gland (P,0.001) and over 300 fold greater than peripheral blood
leukocytes(P,0.001;Fig.2B).Finally,separatingthecellsaccording
to CD14 expression revealed that 1a-OHase was predominantly
expressed in the CD14
+ cells from the infected mammary glands
(P,0.001) compared to CD14
2 cells from the infected gland, but
not in CD14
+ cells from peripheral blood (Fig. 2C). CD14 is a
marker for monocytes and macrophages [22] and typically 10% of
the cells isolated from the milk of the infected mammary gland were
CD14
+ cells (Fig. 2D–F).
Expression of the VDR and vitamin D responsive genes
during mammary infection
The effects of 1,25(OH)2D3 on gene expression depend on the
presence of the VDR. We measured VDR gene expression to find if
it was more abundant in the infected mammary gland. VDR
expression was slightly higher in mammary tissue from the infected
mammary gland than in tissue from the contra-lateral uninfected
mammary gland (Fig. 3A). However, VDR expression in the cells
isolated from milk of the infected mammary gland was 8 fold higher
than VDR expression in cells from the contra-lateral uninfected
mammary gland (P,0.05) and 75 fold higher than VDR expression
in peripheral blood leukocytes (P,0.001; Fig. 3B). In the cells from
the infected mammary gland, there was no difference of VDR
expression between the CD14
+ and CD14
2 populations (Fig. 3C).
In both populations though, VDR expression was at 50 fold greater
in the cells from the infected mammary gland than in peripheral
blood leukocytes (P,0.05) (Fig. 3C).
The 24-OHase gene expression was 50 fold higher in the
infected mammary glands relative to 24-OHase expression in the
contra-lateral uninfected mammary glands (P,0.001; Fig. 4A).
The 24-OHase expression in cells isolated from milk was 4 fold
higher in cells from the infected mammary gland than in cells from
the contra-lateral uninfected mammary gland or peripheral blood
(P,0.05; Fig. 4B). During bacterial infection, 24-OHase expres-
sion was not significantly higher in CD14
+ cells from the infected
glands compared to the CD14
+ cells from blood, but was higher in
CD14
2 cells from the infected glands compared to CD14
2 cells
from blood (P,0.05; Fig. 4C).
Figure 2. 1a-OHase gene expression during S. uberis mammary infection. (A–C) Relative 1a-OHase gene expression in mammary tissue
during infection (A), total cells from blood and milk prior to and during mammary infection (B), and CD14
+ cells and CD14
2 cells from blood and milk
during mammary infection. (A) Three cows were infected with S. uberis and mammary tissue was collected from control and infected glands. (B and
C) Five other cows were infected with S. uberis and cells (mononuclear and polymorphonuclear) were collected from blood and milk from the control
and infected glands prior to and during infection. (C) Blood and milk cells from the infected gland were separated according to CD14 expression on
the cell surface using FACS. The amount of 1a-OHase mRNA in each sample was determined by quantitative real-time RT-PCR and normalized to RPS9
mRNA. The relative amount of 1a-OHase mRNA was determined using the 2
-DDCt method. Data represent the mean 6 SE expression of 1a-OHase
relative to 1a-OHase expression in control tissue (A), or peripheral blood leukocytes (B and C). ANOVA was performed by SAS using the general
linear model and multiple comparison tests were made using the Tukey adjustment; ***mean is different from other means, P,0.001. (D and E)
Scatter plots of all cells and CD14
+ cells isolated from milk from an infected gland. (F) Representative histogram of CD14 expression on cells isolated
from the milk from the infected gland.
doi:10.1371/journal.pone.0015469.g002
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expression of iNOS and RANTES [8]; so, we measured the
expression of both genes in mammary tissue and cells from the
control and in vivo infected mammary glands (Fig. 4D–I). iNOS
and RANTES expression was greater (P,0.001 for iNOS and
P,0.05 for RANTES) in tissue and cells from the infected
mammary glands than in tissue or cells from the contra-lateral
uninfected mammary glands. Like 1a-OHase, iNOS was predom-
inantly expressed in the CD14
+ cells from the infected gland
(P,0.001 compared to CD14
2 cells from the infected glands).
RANTES, however, was expressed more in the CD14
2
population from the infected glands compared to CD14
+ cells
from the infected glands (P,0.05).
Discussion
Numerous in vitro studies have shown that 1a-OHase
expression and subsequent 1,25(OH)2D3 induction of 24-OHase
in monocytes and macrophages is induced by TLR signaling in
vitro [6,8,19]. However, there was a lack of in vivo evidence that
the vitamin D pathway was induced in macrophages in response to
infection. Genes of the vitamin D pathway were elevated in
macrophages in lesions of leprosy patients [10] but that evidence
could not confirm whether or not the pathway was upregulated in
response to infection. In this study, we give in vivo confirmation
that genes of the vitamin D signaling pathway were upregulated in
response to bacterial infection. Furthermore, macrophages at the
site of the bacterial infection were the predominant cells that
expressed 1a-OHase, which confirms the many in vitro studies
that have shown that 1a-OHase is expressed in macrophages upon
pathogen recognition.
Induction of 1a-OHase gene expression in the infected
mammary gland has major implications because it allows for
local control of 1,25(OH)2D3 synthesis. In addition to upregulation
of 1a-OHase, VDR gene expression was elevated in cells from the
infected mammary gland. Increased VDR expression would have
enhanced the sensitivity of those cells to 1,25(OH)2D3. Induction
of 1a-OHase and VDR expression, consequently allowed for
control of vitamin D responsive genes in the infected mammary
glands. During bacterial infection, 24-OHase, iNOS and
RANTES were expressed in the infected mammary glands.
Cathelicidin genes have previously been shown to not be regulated
by 1,25(OH)2D3 in cattle, in contrast to other species, and
therefore were not tested [8]. However, induction of 1a-OHase
gene expression in bovine monocytes in the presence of 25(OH)D3
resulted in upregulation of iNOS and RANTES [8]. Accordingly,
upregulation of iNOS and RANTES expression in monocytes is in
part depended on local 1a-OHase activity and 1,25(OH)2D3
production. Likewise, the expression of 24-OHase is known to be
highly upregulated by 1,25(OH)2D3 [23,24]. The upregulation of
24-OHase in the infected mammary glands indicates that
1,25(OH)2D3 was synthesized locally in the infected mammary
glands. Altogether, our data provides in vivo evidence that a
vitamin D signaling mechanism is activated as part of the innate
immune response to pathogens in order to provide local control of
vitamin D-dependent immune responses.
The substrate for 1a-OHase is 25(OH)D3, so production of
1,25(OH)2D3 and subsequently regulation of gene expression by
1,25(OH)2D3, depends on the availability of 25(OH)D3. The
circulating concentration of 25(OH)D3 depends on dietary intake
of vitamin D and exposure to sunlight [25,26]. In cattle
supplemented with the recommended amount of vitamin D, the
circulating concentration of 25(OH)D3 typically ranges from 20 to
50 ng/mL [27]. Circulating concentrations of 25(OH)D above
20 ng/mL have been considered adequate for calcium homeosta-
sis [28], however, circulating 25(OH)D concentrations below
30 ng/mL are now considered insufficient for proper immune
function in humans [1,29,30]. The target range for 25(OH)D in
humans still remains elusive, however, because of the inability to
perform tightly controlled experiments with human subjects.
Similarities between cattle and humans in regards to vitamin D
metabolism and immune function [31,32,33] indicate that cattle
are a useful model to study vitamin D requirements for proper
immune function in humans. Experiments to find an optimal
range of circulating 25(OH)D for proper immune function in
cattle, however, have not been performed. Therefore, efforts to
find the optimal range of 25(OH)D concentration for proper
immune function in cattle has implications for bovine and human
health.
Figure 3. VDR gene expression during mammary S. uberis infection. Relative VDR gene expression in mammary tissue during an infection
(A), total cells from blood and milk prior to and during mammary infection (B), and CD14
+ cells and CD14
2 cells from blood and milk during
mammary infection (C). Tissue (n=3 cows) and cells (n=5 cows) were collected as in Figure 2. The amount of VDR mRNA in each sample was
determined by quantitative real-time RT-PCR and normalized to RPS9 mRNA. The relative amount of VDR mRNA was determined using the 2
-DDCt
method. Data represent the mean 6 SE expression of VDR relative to VDR expression in control tissue (A), or peripheral blood leukocytes (B and C).
ANOVA was performed by SAS using the general linear model and multiple comparison tests were made using the Tukey adjustment; *mean is
different from other means, P,0.05.
doi:10.1371/journal.pone.0015469.g003
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during mammary infection but the there was not a detectable
increase of 1,25(OH)2D in milk from the infected mammary gland
compared to milk from an uninfected mammary gland. In fact
milk 1,25(OH)2D3 was at or below the detection limits of the assay
(data not shown) This was expected as the concentration of
vitamin D metabolites is are low in milk compared to plasma
[27,34], and the 1,25(OH)2D3 produced by macrophages would
have been diluted as milk accumulated in the cistern of the
mammary gland.
The mean blood concentration of 25(OH)D in the cows used in
this study was 74.5 ng/ml (SEM +/24.5), which is above the
25OHD3 threshold needed for innate immune cells to produce
1,25(OH)2D3 [8,35]. The increased expression of the 1a-OHase
Figure 4. Expresssion of 1,25(OH)2D3 inducible genes during mammary infection. Relative 24-OHase (A–C), iNOS (D–F), and RANTES (G–I)
gene expression in mammary tissue, cells from peripheral blood and cell from milk during mammary infection. Tissue (n=3 cows) and cells (n=5
cows) were collected and sorted as in Figure 2. The amount of mRNA for each gene in each sample was determined by quantitative real-time RT-PCR
and normalized to RPS9 mRNA. The relative amount of mRNA for each gene was determined using the 2
-DDCt method. Data represent the mean 6 SE
expression of each gene relative to expression in control tissue (A), or peripheral blood leukocytes (B and C). ANOVA was performed by SAS
using the general linear model and multiple comparison tests were made using the Tukey adjustment; mean is different from other means* P,0.05,
*** P,0.001.
doi:10.1371/journal.pone.0015469.g004
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PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e15469we observed in innate immune cells from infected mammary tissue
along with the subsequent induction of 24-OHase in these cells
supports the conclusion of local in vivo production of 1,25(OH)2D3
during an infection. We show for the first time that an in vivo
infection results in activation of vitamin D with the concomitant
downstream vitamin D dependant genes of the innate immune
system activated similar to that previously observed in vivo.
Acknowledgments
We thank Duane Zimmerman, Randy Atchison, Derrel Hoy and Bruce
Pesch (USDA National Animal Disease Center, Ames, IA) for their
technical assistance. We also thank Mitch Palmer (USDA National Animal
Disease Center, Ames, IA) for his critical review of this manuscript.
Author Contributions
Conceived and designed the experiments: CN TR DB JL. Performed the
experiments: CN JL. Analyzed the data: CN TR DB JL. Contributed
reagents/materials/analysis tools: CN TR DB JL. Wrote the paper: CN
TR JL.
References
1. Adams JS, Hewison M (2010) Update in vitamin d. J Clin Endocrinol Metab 95:
471–478.
2. Horst RL, Goff JP, Reinhardt TA (2003) Role of vitamin D in calcium
homeostasis and its use in prevention of bovine periparturient paresis. Acta Vet
Scand Suppl 97: 35–50.
3. DeLuca HF (1975) The kidney as an endocrine organ involved in the function of
vitamin D. Am J Med 58: 39–47.
4. Engstrom GW, Goff JP, Horst RL, Reinhardt TA (1987) Regulation of calf renal
25-hydroxyvitamin D-hydroxylase activities by calcium-regulating hormones.
J Dairy Sci 70: 2266–2271.
5. Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, et al. (2008) IL-15 links
TLR2/1-induced macrophage differentiation to the vitamin D-dependent
antimicrobial pathway. J Immunol 181: 7115–7120.
6. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor
triggering of a vitamin D-mediated human antimicrobial response. Science 311:
1770–1773.
7. Stoffels K, Overbergh L, Bouillon R, Mathieu C (2007) Immune regulation of
1alpha-hydroxylase in murine peritoneal macrophages: unravelling the IFN-
gamma pathway. J Steroid Biochem Mol Biol 103: 567–571.
8. Nelson CD, Reinhardt TA, Thacker TC, Beitz DC, Lippolis JD (2010)
Modulation of the bovine innate immune response by production of 1alpha,25-
dihydroxyvitamin D(3) in bovine monocytes. J Dairy Sci 93: 1041–1049.
9. Hewison M (2010) Vitamin D and the intracrinology of innate immunity. Mol
Cell Endocrinol DOI: 10.1016/j.mce.2010.02.013.
10. Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, et al. (2009) Divergence of
macrophage phagocytic and antimicrobial programs in leprosy. Cell Host
Microbe 6: 343–353.
11. Bruce D, Ooi JH, Yu S, Cantorna MT (2010) Vitamin D and host resistance to
infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) 235:
921–927.
12. Hogan J, Larry Smith K (2003) Coliform mastitis. Vet Res 34: 507–519.
13. Olde Riekerink RG, Barkema HW, Kelton DF, Scholl DT (2008) Incidence rate
of clinical mastitis on Canadian dairy farms. J Dairy Sci 91: 1366–1377.
14. Petrovski KR, Heuer C, Parkinson TJ, Williamson NB (2009) The incidence and
aetiology of clinical bovine mastitis on 14 farms in Northland, New Zealand.
N Z Vet J 57: 109–115.
15. Sampimon O, Barkema HW, Berends I, Sol J, Lam T (2009) Prevalence of
intramammary infection in Dutch dairy herds. J Dairy Res 76: 129–136.
16. Riollet C, Rainard P, Poutrel B (2000) Cells and cytokines in inflammatory
secretions of bovine mammary gland. Adv Exp Med Biol 480: 247–258.
17. Reinhardt TA, Lippolis JD (2006) Bovine milk fat globule membrane proteome.
J Dairy Res 73: 406–416.
18. De Schepper S, De Ketelaere A, Bannerman DD, Paape MJ, Peelman L, et al.
(2008) The toll-like receptor-4 (TLR-4) pathway and its possible role in the
pathogenesis of Escherichia coli mastitis in dairy cattle. Vet Res 39: 5.
19. Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, et al. (2006)
Immune regulation of 25-hydroxyvitamin-D3-1-hydroxylase in human mono-
cytes. Journal of Bone and Mineral Research 21: 37–47.
20. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
21. Bannerman DD, Paape MJ, Goff JP, Kimura K, Lippolis JD, et al. (2004) Innate
immune response to intramammary infection with Serratia marcescens and
Streptococcus uberis. Vet Res 35: 681–700.
22. Brodersen R, Bijlsma F, Gori K, Jensen KT, Chen W, et al. (1998) Analysis of
the immunological cross reactivities of 213 well characterized monoclonal
antibodies with specificities against various leucocyte surface antigens of human
and 11 animal species. Vet Immunol Immunopathol 64: 1–13.
23. Reinhardt TA, Koszewski NJ, Omdahl J, Horst RL (1999) 1,25-Dihydrox-
yvitamin D(3) and 9-cis-retinoids are synergistic regulators of 24-hydroxylase
activity in the rat and 1, 25-dihydroxyvitamin D(3) alters retinoic acid
metabolism in vivo. Arch Biochem Biophys 368: 244–248.
24. Vaisanen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C (2005) Spatio-
temporal activation of chromatin on the human CYP24 gene promoter in the
presence of 1alpha,25-Dihydroxyvitamin D3. J Mol Biol 350: 65–77.
25. Wagner CL, Taylor SN, Hollis BW (2008) Does vitamin D make the world go
‘round’? Breastfeed Med 3: 239–250.
26. Horst RL, Reinhardt TA (1983) Vitamin D metabolism in ruminants and its
relevance to the periparturient cow. J Dairy Sci 66: 661–678.
27. McDermott CM, Beitz DC, Littledike ET, Horst RL (1985) Effects of dietary
vitamin D3 on concentrations of vitamin D and its metabolites in blood plasma
and milk of dairy cows. J Dairy Sci 68: 1959–1967.
28. NRC (2001) Nutrient Requirements of Dairy Cattle: Seventh Revised Edition.
Washington, DC: Natl. Acad. Sci.
29. Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with
health consequences. Am J Clin Nutr 87: 1080S–1086S.
30. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin
D sufficiency: implications for establishing a new effective dietary intake
recommendation for vitamin D. J Nutr 135: 317–322.
31. Horst RL, Goff JP, Reinhardt TA (2005) Adapting to the transition between
gestation and lactation: differences between rat, human and dairy cow.
J Mammary Gland Biol Neoplasia 10: 141–156.
32. Van Rhijn I, Godfroid J, Michel A, Rutten V (2008) Bovine tuberculosis as a
model for human tuberculosis: advantages over small animal models. Microbes
Infect 10: 711–715.
33. Endsley JJ, Waters WR, Palmer MV, Nonnecke BJ, Thacker TC, et al. (2009)
The calf model of immunity for development of a vaccine against tuberculosis.
Vet Immunol Immunopathol 128: 199–204.
34. Hollis BW, Roos BA, Draper HH, Lambert PW (1981) Vitamin D and its
metabolites in human and bovine milk. J Nutr 111: 1240–1248.
35. Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, et al. (2007) Extra-
renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease.
J Steroid Biochem Mol Biol 103: 316–321.
Activation of Vitamin D Pathway during Infection
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15469